Liquidia's average Accounts Receivable for the
three
months ended in Mar. 2024 was $3.32 Mil. Liquidia's Revenue for the
three
months ended in Mar. 2024 was $2.97 Mil.
Hence, Liquidia's Days Sales Outstanding for the
three
months ended in Mar. 2024 was 101.80.
The historical rank and industry rank for Liquidia's Days Sales Outstanding or its related term are showing as below:
LQDA'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 12.34 Med: 84.91 Max: 127.76
Current: 83.19
During the past 8 years, Liquidia's highest Days Sales Outstanding was 127.76. The lowest was 12.34. And the median was 84.91.
LQDA's Days Sales Outstanding is ranked worse than 57.32% of 888
companies
in the Biotechnology industry
Industry Median: 72.34
vs LQDA: 83.19
Liquidia's Days Sales Outstanding
increased
from Mar. 2023 (92.90) to Mar. 2024 (101.80).
Liquidia Days Sales Outstanding Historical Data
The historical data trend for Liquidia's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Liquidia's Days Sales Outstanding
For the Biotechnology subindustry, Liquidia's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Liquidia's Days Sales Outstanding Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Liquidia's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Liquidia's Days Sales Outstanding falls into.
Liquidia Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Liquidia (NAS:LQDA) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Liquidia Days Sales Outstanding Related Terms
Thank you for viewing the detailed overview of Liquidia's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH). It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles designed to improve the safety, efficacy, and performance of a wide range of therapies. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LQDA has been successfully added to your 